Targeting chemokines in aortic aneurysm: could this be key to a novel therapy for a common problem?
- PMID: 23486768
- DOI: 10.1161/ATVBAHA.112.301004
Targeting chemokines in aortic aneurysm: could this be key to a novel therapy for a common problem?
Comment on
- 
  
  Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):718-26. doi: 10.1161/ATVBAHA.112.300329. Epub 2013 Jan 3. Arterioscler Thromb Vasc Biol. 2013. PMID: 23288157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        